Life Edit Therapeutics

Life Edit Therapeutics

Biotechnology, 300 Morris St, Durham, North Carolina, 27701, United States, 51-200 Employees

lifeeditinc.com

  • twitter
  • LinkedIn

phone no Phone Number: 91********

Who is LIFE EDIT THERAPEUTICS

Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the worlds largest and most diverse collections of no...

Read More

map
  • 300 Morris St, Durham, North Carolina, 27701, United States Headquarters: 300 Morris St, Durham, North Carolina, 27701, United States
  • 2017 Date Founded: 2017
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from LIFE EDIT THERAPEUTICS

Life Edit Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Life Edit Therapeutics

Answer: Life Edit Therapeutics's headquarters are located at 300 Morris St, Durham, North Carolina, 27701, United States

Answer: Life Edit Therapeutics's phone number is 91********

Answer: Life Edit Therapeutics's official website is https://lifeeditinc.com

Answer: Life Edit Therapeutics's revenue is $10 Million to $25 Million

Answer: Life Edit Therapeutics's SIC: 2834

Answer: Life Edit Therapeutics has 51-200 employees

Answer: Life Edit Therapeutics is in Biotechnology

Answer: Life Edit Therapeutics contact info: Phone number: 91******** Website: https://lifeeditinc.com

Answer: Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the worlds largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The platform allows Life Edit to target any genomic sequence and develop novel human therapeutics for the most challenging genetic diseases by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies. In addition to developing its own pipeline of cell and gene therapies, Life Edit Therapeutics will continue to strengthen its platform of genome-editing enzymes, provide gene-editing expertise to strategic partners, and form other third-party partnerships to discover and develop new therapies.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access